Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Dermatology

Free Subscription 07.01.2019 6 Am J Dermatopathol 1 Am J Pathol 2 Ann Intern Med 43 Br J Dermatol 3 Clin Dermatol 4 Clin Exp Dermatol 4 Cutis 3 Int J Cancer 12 Int J Dermatol 1 Intern Med 2 J Cutan Pathol 1 J Dermatol 1 J Invest Dermatol 3 N Engl J Med 6 Plast Reconstr Surg 8 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Dermatopathol

1. TRAN TAN, Grow WB, Chang CC
   Superficial and Deep Cutaneous Involvement by RAS-Associated Autoimmunne Leukoproliferative Disease (RALD Cutis): A Histologic Mimicker of Histiocytoid Sweet Syndrome.
   Am J Dermatopathol. 2018 Dec 26. doi: 10.1097/DAD.0000000000001332.
   PubMed     Text format     Abstract available
   
   
2. HUI ONG EL, Sinha R, Jmor S, Fearfield L, et al
   BRAF Inhibitor-Associated Granulomatous Dermatitis: A Report of 3 Cases.
   Am J Dermatopathol. 2018 Dec 21. doi: 10.1097/DAD.0000000000001276.
   PubMed     Text format     Abstract available
   
   
3. AMARASEKERA D, Connolly D, Gochoco A, Yang S, et al
   Cutaneous B-Cell Lymphoblastic Lymphoma.
   Am J Dermatopathol. 2018 Dec 20. doi: 10.1097/DAD.0000000000001347.
   PubMed     Text format     Abstract available
   
   
4. ELWYN LB, Combs A, Villada G, Poulos E, et al
   Localized Lichen Myxedematosus With Plasma Cell Light Chain Restriction. Is It the Exception or the Rule?
   Am J Dermatopathol. 2018 Dec 20. doi: 10.1097/DAD.0000000000001335.
   PubMed     Text format     Abstract available
   
   
5. ELBENDARY A, Valdebran M, Xue R
   Violaceous Papules Presenting on the Foot and Lower Limb: Challenge.
   Am J Dermatopathol. 2018 Dec 19. doi: 10.1097/DAD.0000000000001330.
   PubMed     Text format    
   
   
6. GEORGE EV, Kalen JE, Kapil JP, Motaparthi K, et al
   Comparison of the Inflammatory Infiltrates in Tumoral Melanosis, Regressing Nevi, and Regressing Melanoma.
   Am J Dermatopathol. 2018 Dec 19. doi: 10.1097/DAD.0000000000001346.
   PubMed     Text format     Abstract available
   
   

   
   Am J Pathol

7. MUZUMDAR S, Hiebert H, Haertel E, Ben-Yehuda Greenwald M, et al
   Nrf2-mediated expansion of pilosebaceous cells accelerates cutaneous wound healing.
   Am J Pathol. 2018 Dec 26. pii: S0002-9440(18)30652.
   PubMed     Text format     Abstract available
   
   

   
   Ann Intern Med

8. CLEMENTS ML
   Lie to me: Tell me bald is beautiful.
   Ann Intern Med. 2018;168:373-374.
   PubMed     Text format    
   
   
9. WELCH HG, Brawley OW
   Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors.
   Ann Intern Med. 2018;168:143-144.
   PubMed     Text format    
   
   

   
   Br J Dermatol

10. MOSS C
    RASopathies and the skin.
    Br J Dermatol. 2019;180:21.
    PubMed     Text format    
    
    
11. DANIELSEN K
    Increased risk of death in patients with psoriasis: disease or lifestyle?
    Br J Dermatol. 2019;180:3-4.
    PubMed     Text format    
    
    
12. SCHILLING B, Wiesner T
    Tackling melanoma by adjuvant therapy: why, whom and how?
    Br J Dermatol. 2019;180:1-2.
    PubMed     Text format    
    
    
13. MAGIN P
    Patient preferences and patient-centredness in skin cancer care: implications for clinicians and patient management.
    Br J Dermatol. 2019;180:22-23.
    PubMed     Text format    
    
    
14. CHONG BF
    Applying the Cutaneous Lupus Erythematosus Disease Area and Severity Index to paediatric cutaneous lupus erythematosus.
    Br J Dermatol. 2019;180:20-21.
    PubMed     Text format    
    
    
15. GISONDI P, Girolomoni G
    The multifaceted association between psoriasis and obesity.
    Br J Dermatol. 2019;180:24.
    PubMed     Text format    
    
    
16. GARCIA-DOVAL I, Davila-Seijo P
    How real are 'real-life studies' in psoriasis, and the uncertain meaning of drug persistence.
    Br J Dermatol. 2019;180:15-16.
    PubMed     Text format    
    
    
17. DAVILA-SEIJO P, Descalzo MA
    Registries as real-world cohort studies that are useful and necessary in the pyramid of evidence.
    Br J Dermatol. 2018;178:300-301.
    PubMed     Text format    
    
    
18. EADIE E, Ibbotson SH, Dawe RS
    Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythema dose.
    Br J Dermatol. 2018;178:297-298.
    PubMed     Text format    
    
    
19. ORMEROD AD
    Dutch guidelines for psoriasis treatment.
    Br J Dermatol. 2019;180:11.
    PubMed     Text format    
    
    
20. CRIADO PR
    What lessons can we learn from an apparent decrease in the use of topical drugs for psoriasis?
    Br J Dermatol. 2019;180:19.
    PubMed     Text format    
    
    
21. BAKKER DS, Ariens LFM, van Luijk C, van der Schaft J, et al
    Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis.
    Br J Dermatol. 2018 Dec 30. doi: 10.1111/bjd.17538.
    PubMed     Text format     Abstract available
    
    
22. VAN EGMOND S, Wakkee M, van Rengen A, Bastiaens MT, et al
    Factors influencing current low-value follow-up care after basal cell carcinoma and suggested strategies for de-adoption: a qualitative study.
    Br J Dermatol. 2018 Dec 30. doi: 10.1111/bjd.17594.
    PubMed     Text format     Abstract available
    
    
23. LARSEN MH, Strumse YAS, Borge CR, Osborne R, et al
    Health literacy - a new piece of the puzzle in psoriasis care?
    Br J Dermatol. 2018 Dec 31. doi: 10.1111/bjd.17595.
    PubMed     Text format     Abstract available
    
    
24. FLEMING P
    Tofacitinib: a new oral Janus kinase inhibitor for psoriasis.
    Br J Dermatol. 2019;180:13-14.
    PubMed     Text format    
    
    
25. O'SHAUGHNESSY RFL
    Targeting tryptophan transport and breakdown in basal cell carcinoma.
    Br J Dermatol. 2019;180:16-17.
    PubMed     Text format    
    
    
26. GRANTHAM HJ, Reynolds NJ
    The devil is in the data: differences in drug persistence between SNIIRAM, the French national health insurance database, and psoriasis biologics intervention registers.
    Br J Dermatol. 2019;180:8-10.
    PubMed     Text format    
    
    
27. VAN AKKOOI ACJ, Hayes A
    Recent developments in lymph node surgery for melanoma.
    Br J Dermatol. 2019;180:5-7.
    PubMed     Text format    
    
    
28. VAN DER KRAAIJ GE, Balak DMW, Busard CI, van Cranenburgh OD, et al
    Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.
    Br J Dermatol. 2019;180:31-42.
    PubMed     Text format    
    
    
29. RYAN C
    Adalimumab treatment for psoriasis - safety in numbers.
    Br J Dermatol. 2019;180:14-15.
    PubMed     Text format    
    
    
30. ALBRECHT J, Mehta S, Bigby M
    Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to 'Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?'
    Br J Dermatol. 2018;178:300.
    PubMed     Text format    
    
    
31. JONKMAN MF, Meijer JM, Diercks GFH, Pas HH, et al
    Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis'.
    Br J Dermatol. 2018;178:573.
    PubMed     Text format    
    
    
32. GAMBICHLER T, Wolf P
    Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythemal dose: reply from the authors.
    Br J Dermatol. 2018;178:298-299.
    PubMed     Text format    
    
    
33. SCHMITT-EGENOLF M
    What can we learn from 'dropouts' in clinical trials?
    Br J Dermatol. 2018;178:318-319.
    PubMed     Text format    
    
    
34. VENDER R
    Survival of the fittest.
    Br J Dermatol. 2018;178:328-329.
    PubMed     Text format    
    
    
35. BAGATIN E
    Treating actinic keratosis: assessment of effectiveness, discomfort, costs and follow-up.
    Br J Dermatol. 2018;178:322-323.
    PubMed     Text format    
    
    
36. NAIK HB, Abuabara K
    Systematic reviews of case reports and case series: from anecdote to evidence.
    Br J Dermatol. 2018;178:317-318.
    PubMed     Text format    
    
    
37. HOLMES S
    Alopecia: the questions we need to answer.
    Br J Dermatol. 2018;178:330-331.
    PubMed     Text format    
    
    
38. CARMICHAEL AJ, Harman KE
    Orf - a potential trigger for self-limiting epidermolysis bullosa acquisita-like blistering.
    Br J Dermatol. 2018;178:333.
    PubMed     Text format    
    
    
39. STICHERLING M
    Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers?
    Br J Dermatol. 2018;178:333-334.
    PubMed     Text format    
    
    
40. VON SCHUCKMANN LA
    Is occupational sun exposure important for squamous cell carcinoma risk?
    Br J Dermatol. 2018;178:325-326.
    PubMed     Text format    
    
    
41. SACH T
    Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid.
    Br J Dermatol. 2018;178:320-321.
    PubMed     Text format    
    
    
42. KEEGEL T, Nixon RL
    Wet work and healthcare workers: use of hand disinfectants not associated with self-reported eczema.
    Br J Dermatol. 2018;178:324-325.
    PubMed     Text format    
    
    
43. MCGRATH JA
    Concurrent hidradenitis suppurativa and Dowling-Degos disease taken down a 'Notch'.
    Br J Dermatol. 2018;178:328.
    PubMed     Text format    
    
    
44. HERTL M, Hashimoto T
    Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis': reply from authors.
    Br J Dermatol. 2018;178:573-574.
    PubMed     Text format    
    
    
45. DRUCKER AM, Doiron PR
    Understanding common but understudied diseases in dermatology.
    Br J Dermatol. 2018;178:22-23.
    PubMed     Text format    
    
    
46. TEASDALE E
    The benefit of nested qualitative studies in dermatology randomized controlled trials.
    Br J Dermatol. 2018;178:25-26.
    PubMed     Text format    
    
    
47. ALBRECHT J, Gerdes S
    When to switch biologics: some answers, but lots of questions too.
    Br J Dermatol. 2018;178:20.
    PubMed     Text format    
    
    
48. HWANG SJE, Fernandez-Penas P
    Pigmentary evolution with pembrolizumab use.
    Br J Dermatol. 2018;178:32-33.
    PubMed     Text format    
    
    
49. EZZEDINE K, Eleftheriadou V
    Vitiligo and quality of life: the dark face of whiteness.
    Br J Dermatol. 2018;178:28-29.
    PubMed     Text format    
    
    
50. FELDMAN SR
    Yet another step forward!
    Br J Dermatol. 2018;178:22.
    PubMed     Text format    
    
    
51. COHEN AD, Zisman D
    Growing evidence for coronary artery disease risk factors in patients with severe hidradenitis suppurativa.
    Br J Dermatol. 2018;178:27-28.
    PubMed     Text format    
    
    
52. APFELBACHER C
    The time healthcare workers wear disposable gloves daily is associated with hand eczema in a dose-dependent fashion.
    Br J Dermatol. 2018;178:323-324.
    PubMed     Text format    
    
    

    
    Clin Dermatol

53. LEVY ML
    Developing an eczema action plan.
    Clin Dermatol. 2018;36:659-661.
    PubMed     Text format     Abstract available
    
    
54. GROSSMAN SK, Schut C, Kupfer J, Valdes-Rodriguez R, et al
    Experiences with the first eczema school in the United States.
    Clin Dermatol. 2018;36:662-667.
    PubMed     Text format     Abstract available
    
    
55. KU MC, Teh LS, Chen PM, Yang TI, et al
    Synergistic effect of platelet-rich plasma injections and scalp lifting in androgenetic alopecia.
    Clin Dermatol. 2018;36:673-679.
    PubMed     Text format     Abstract available
    
    

    
    Clin Exp Dermatol

56. SINDHUJA T, Vinay K, Parsad D, Kumaran MS, et al
    Coexisting cutaneous disorders in vitiligo: a retrospective analysis.
    Clin Exp Dermatol. 2019 Jan 2. doi: 10.1111/ced.13889.
    PubMed     Text format    
    
    
57. MAAROUF M, Hendricks A, Culpepper KS, Shi VY, et al
    Multiple eruptive cutaneous horns on the scalp.
    Clin Exp Dermatol. 2019 Jan 2. doi: 10.1111/ced.13866.
    PubMed     Text format    
    
    
58. GARBAYO-SALMONS P, Casulleras-Gonzalez A, Agut-Busquet E, Saez-Artacho E, et al
    Giant cutaneous pleomorphic fibroma: an unusual presentation.
    Clin Exp Dermatol. 2018 Dec 30. doi: 10.1111/ced.13875.
    PubMed     Text format    
    
    
59. SABATER-MARCO V, Ballester-Sanchez R, Navarro-Cervero L, Fuster-Diana C, et al
    Primary cutaneous embryonal rhabdomyosarcoma with desmoplastic growth pattern and anaplastic lymphoma kinase overexpression. Report of a case with special emphasis on the differential diagnosis.
    Clin Exp Dermatol. 2018 Dec 30. doi: 10.1111/ced.13877.
    PubMed     Text format    
    
    

    
    Cutis

60. GRGURICH E, Gupta N, Owen R, Purcell SM, et al
    Inflammatory linear verrucous epidermal nevus responsive to 308-nm excimer laser treatment.
    Cutis. 2018;102:111-114.
    PubMed     Text format     Abstract available
    
    
61. BLEICHER B, Levine A, Markowitz O
    Going digital with dermoscopy.
    Cutis. 2018;102:102-105.
    PubMed     Text format     Abstract available
    
    
62. LUNDGREN AD
    Bedside microscopy for the beginner.
    Cutis. 2018;102:E27-E30.
    PubMed     Text format     Abstract available
    
    
63. WOODY MM, Holliday AC, Gavino ACP, McReynolds A, et al
    Metastatic vulvovaginal Crohn disease in the setting of well-controlled intestinal disease.
    Cutis. 2018;102:E16-E18.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

64. OH H, Pfeiffer RM, Falk RT, Horne HN, et al
    Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Int J Cancer. 2018;143:496-507.
    PubMed     Text format     Abstract available
    
    
65. KWOK ZH, Roche V, Chew XH, Fadieieva A, et al
    A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers.
    Int J Cancer. 2018;143:668-678.
    PubMed     Text format     Abstract available
    
    
66. GUINTER MA, McLain AC, Merchant AT, Sandler DP, et al
    A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women.
    Int J Cancer. 2018 Mar 25. doi: 10.1002/ijc.31387.
    PubMed     Text format     Abstract available
    
    

    
    Int J Dermatol

67. LEE WJ, Moon IJ, Shin HJ, Won CH, et al
    CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
    Int J Dermatol. 2018 Dec 30. doi: 10.1111/ijd.14362.
    PubMed     Text format     Abstract available
    
    
68. PHAN K, Loya A
    Mohs micrographic surgery versus wide local excision for melanoma in situ: analysis of a nationwide database.
    Int J Dermatol. 2019 Jan 3. doi: 10.1111/ijd.14374.
    PubMed     Text format     Abstract available
    
    
69. DAVILA JJ, Aguilar K, Cabrera F, Boadas A, et al
    Dermoscopic features of acral basal cell carcinoma.
    Int J Dermatol. 2019 Jan 3. doi: 10.1111/ijd.14375.
    PubMed     Text format    
    
    
70. PARTARRIEU-MEJIAS F, Diaz-Corpas T, Perez-Ferriols A, Alegre-de Miquel V, et al
    Mycosis fungoides after treatment with tumor necrosis factor-alpha inhibitors for psoriasis: progression or onset?
    Int J Dermatol. 2019 Jan 3. doi: 10.1111/ijd.14367.
    PubMed     Text format    
    
    
71. FATHI R, Sendelweck MA, Dunnick CA, Stevens R, et al
    A hyperpigmented rash on face and chest.
    Int J Dermatol. 2018;57:791-793.
    PubMed     Text format    
    
    
72. ABDELRAHMAN W, Shum L, McManus D, Walsh MY, et al
    Eosinophilic polymorphic and pruritic eruption associated with radiotherapy in a patient with primary nodal Merkel cell carcinoma.
    Int J Dermatol. 2018;57:864-866.
    PubMed     Text format    
    
    
73. KOVITWANICHKANONT T, Driscoll T
    A comparative review of the isotretinoin pregnancy risk management programs across four continents.
    Int J Dermatol. 2018;57:1035-1046.
    PubMed     Text format     Abstract available
    
    
74. RIVAS-CALDERON MK, Moran-Villasenor E, Maza-Ramos G, Orozco-Covarrubias L, et al
    Eruptive pseudoangiomatosis in two children with acute lymphoblastic leukemia.
    Int J Dermatol. 2018;57:e38-e40.
    PubMed     Text format    
    
    
75. COHEN PR
    Notalgia paresthetica: cryolipolysis as a novel potential treatment.
    Int J Dermatol. 2018;57:e52.
    PubMed     Text format    
    
    
76. HIRAIWA T, Yamamoto T
    Comorbidities of Japanese patients with palmoplantar pustulosis: a report from a single center.
    Int J Dermatol. 2018;57:e40-e41.
    PubMed     Text format    
    
    
77. CHANDAN N, Juhl ME, Tsoukas MM
    Brunsting-Perry pemphigoid: a case with antigen identification.
    Int J Dermatol. 2018;57:e41-e43.
    PubMed     Text format    
    
    
78. LAIRD ME, Sukhdeo K, Ho A, Hoffmann RK, et al
    Concentric targetoid scaly plaques in a patient with severe rheumatoid arthritis.
    Int J Dermatol. 2018;57:913-914.
    PubMed     Text format    
    
    

    
    Intern Med

79. HONDA D, Ohsawa I, Shimizu Y, Maiguma M, et al
    Suffocation due to Acute Airway Edema in a Patient with Hereditary Angioedema Highlighted the Need for Urgent Improvements in Treatment Availability in Japan.
    Intern Med. 2018;57:3193-3197.
    PubMed     Text format     Abstract available
    
    

    
    J Cutan Pathol

80. BA W, Yang Y, Zheng L, Lin B, et al
    Erythema elevatum diutinum with pustule formation: An unusual finding.
    J Cutan Pathol. 2018;45:246-248.
    PubMed     Text format    
    
    
81. HAIGES D, Kurz P, Laaff H, Meiss F, et al
    Malignant PEComa.
    J Cutan Pathol. 2018;45:84-89.
    PubMed     Text format    
    
    

    
    J Dermatol

82. KIM HJ, Jang J, Lee EH, Jung S, et al
    Decreased expression of response gene to complement 32 in psoriasis and its association with reduced M2 macrophage polarization.
    J Dermatol. 2019 Jan 2. doi: 10.1111/1346-8138.14733.
    PubMed     Text format    
    
    

    
    J Invest Dermatol

83. RONET C, Passelli K, Charmoy M, Scarpellino L, et al
    TLR2 signaling in skin non-hematopoietic cells induces early neutrophil recruitment in response to Leishmania major infection.
    J Invest Dermatol. 2018 Dec 27. pii: S0022-202X(18)01302.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

84. ROGERS KA, Blachly JS, Grever MR
    Case 28-2018: A Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia.
    N Engl J Med. 2018;379:2381-2382.
    PubMed     Text format    
    
    
85. YAVORKOVSKY LL
    Case 28-2018: A Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia.
    N Engl J Med. 2018;379:2382.
    PubMed     Text format    
    
    
86. BOWLES AA, Smirnov B
    Erythrodermic Psoriasis and HIV Infection.
    N Engl J Med. 2019;380:80.
    PubMed     Text format    
    
    

    
    Plast Reconstr Surg

87. ODOM EB, Mundschenk MB, Hard K, Buck DW 2nd, et al
    The Utility of Hypochlorous Acid Wound Therapy in Wound Bed Preparation and Skin Graft Salvage.
    Plast Reconstr Surg. 2018 Dec 31. doi: 10.1097/PRS.0000000000005359.
    PubMed     Text format    
    
    
88. COHEN O, Lam G, Choi M, Ceradini D, et al
    Risk Factors for Delays in Adjuvant Chemotherapy following Immediate Breast Reconstruction.
    Plast Reconstr Surg. 2018;142:299-305.
    PubMed     Text format     Abstract available
    
    
89. BURM JS, Lee YK, Cho JY
    Treatment of Facial Hypopigmented Scars by the Laser Hole Technique Using a Nonfractional Carbon Dioxide Laser in Asians.
    Plast Reconstr Surg. 2018;142:126e-132e.
    PubMed     Text format     Abstract available
    
    
90. FREY JD, Salibian AA, Karp NS, Choi M, et al
    Comparing Therapeutic versus Prophylactic Nipple-Sparing Mastectomy: Does Indication Inform Oncologic and Reconstructive Outcomes?
    Plast Reconstr Surg. 2018;142:306-315.
    PubMed     Text format     Abstract available
    
    
91. SALO JTK, Tukiainen EJ
    Oncologic Resection and Reconstruction of the Chest Wall: A 19-Year Experience in a Single Center.
    Plast Reconstr Surg. 2018;142:536-547.
    PubMed     Text format     Abstract available
    
    
92. LANS J, van Leeuwen W, Jupiter JB, Eberlin KR, et al
    Treatment of Digital Melanonychia with Atypia.
    Plast Reconstr Surg. 2018;142:439-445.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

93. CHENG Y, Zhao X, Chen Y, Li Y, et al
    Circulating immune complexome analysis identified anti-tubulin-alpha-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
    PLoS One. 2018;13:e0199047.
    PubMed     Text format     Abstract available
    
    
94. CANTANHEDE LM, Fernandes FG, Ferreira GEM, Porrozzi R, et al
    New insights into the genetic diversity of Leishmania RNA Virus 1 and its species-specific relationship with Leishmania parasites.
    PLoS One. 2018;13:e0198727.
    PubMed     Text format     Abstract available
    
    
95. VELASCO-TIRADO V, Alonso-Sardon M, Cosano-Quero A, Romero-Alegria A, et al
    Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).
    PLoS One. 2018;13:e0198582.
    PubMed     Text format     Abstract available
    
    
96. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    PubMed     Text format     Abstract available
    
    
97. CHEN Z, Ai L, Mboge MY, Tu C, et al
    Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    PLoS One. 2018;13:e0199476.
    PubMed     Text format     Abstract available
    
    
98. DEPARDON E, Kanoun S, Humbert O, Bertaut A, et al
    FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
    PLoS One. 2018;13:e0199529.
    PubMed     Text format     Abstract available
    
    
99. GOUSSIA A, Simou N, Zagouri F, Manousou K, et al
    Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
    PLoS One. 2018;13:e0200302.
    PubMed     Text format     Abstract available
    
    
100. HAN X, Zhao J, Ruddy KJ, Lin CC, et al
     The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women.
     PLoS One. 2018;13:e0198771.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: